Company Introduction

Content Management, single-page content, Company Introduction

Shijiazhuang Fourth Pharmaceutical Group (Shijiazhuang Fourth Pharmaceutical Co., LTD.) is a large high-tech pharmaceutical enterprise that focuses on the coordinated development of R&D and industrialization in multiple fields of the pharmaceutical industry chain, including innovative drugs, generic drugs, characteristic raw materials, high-end preparations, and pharmaceutical packaging materials. It has ranked among the top 100 enterprises in China's pharmaceutical industry and the outstanding brand enterprises of China's chemical pharmaceutical industry in terms of preparation export. In 2007, the enterprise was listed on the main board of the Hong Kong Stock Exchange (Stone Pharmaceutical Group 02005.HK). At present, the group has 10 subsidiaries, over 6,500 employees, assets exceeding 10 billion yuan, and main business income exceeding 6 billion yuan. It has developed a diversified business pattern covering the research and development, production, and export of innovative generic drugs, characteristic raw materials, high-end preparations, biological preparations, and pharmaceutical packaging materials. The group has formed a complete industrial chain covering the research and development, production and application of characteristic apis, new dosage forms and pharmaceutical packaging materials. The annual production capacity of injections can reach 4 billion (vials/bottles/bags), and the production scale and technical level are among the top in the same industry. The flexible operation mode, differentiated marketing and service have enabled the group's brand products to win high praise and acclaim from a wide range of customers and consumers. The products cover 32 provinces, municipalities directly under the Central Government and autonomous regions across the country, and are also exported to over 100 countries and regions in Asia, Europe, Africa, America and Oceania.